Sleep Disorders Trial, Recruiting NCT05881031 Sponsor: The Hospital for Sick Children Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05881031
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and teenagers between the ages of 5 and 17 years old
  • Children who have just been prescribed a non-invasive breathing support machine (a mask-based device that helps with breathing, often used during sleep)
  • Children who have already tried using the breathing device while awake and were able to tolerate it
  • Children (and their parent or guardian) who are willing to give consent to participate in the study

Who may not be able to join:

  • Children with certain heart conditions that could make using the breathing device risky, such as a weakened heart, high blood pressure in the lungs, or a specific type of heart defect where only one chamber does the main pumping work (confirm with trial site)
  • Children whose doctor feels they are at high risk of serious complications from using the breathing device, such as a collapsed lung or risk of inhaling food or liquid into the lungs
  • Children with severe sleep-related breathing problems, specifically those with very high carbon dioxide levels or a high number of breathing disruptions per hour during sleep (confirm with trial site)
  • Children who are already taking part in another research study that could affect how well they use their breathing device
  • Children or caregivers who do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Reshma Amin, MD, The Hospital for Sick Children

Phone: (416) 813-7654

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Hospital for Sick Children
Registry
ClinicalTrials.gov
Start date
21 June 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Recruitment and retention rate; Proportion of eligible patients randomized; Proportion of patients that crossover based on safety criteria

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov